-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Edwards Lifesciences Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Edwards Lifesciences Corp Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $40.7M, a 22.8% decline year-over-year.
- Edwards Lifesciences Corp Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $186M, a 3.27% decline year-over-year.
- Edwards Lifesciences Corp annual Income Tax Expense (Benefit) for 2023 was $199M, a 19.1% decline from 2022.
- Edwards Lifesciences Corp annual Income Tax Expense (Benefit) for 2022 was $246M, a 23.4% increase from 2021.
- Edwards Lifesciences Corp annual Income Tax Expense (Benefit) for 2021 was $199M, a 113% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)